Pharmacy-Integrated AI System to Help AD/ADRD Patients Take Meds and Stay Out of the Hospital
Official title: Commercialization of a Pharmacy-Integrated AI System to Improve Medication Adherence and Reduce Hospitalizations in Dementia Care
Funded at Hido Technologies, INC. · NIH-11406017 · Data updated 2026-11-12
A new AI-powered home medication system helps people with Alzheimer’s and related dementias take their medicines correctly to reduce hospital visits and ease caregiving.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hido Technologies, INC. NIH-funded |
| Lab location | 1 site (El Dorado Hills, United States) |
| Project start | September 17, 2026 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,999,331 |
| NIH project number | 1SB1AG099296-01A1 |
| Project ID | NIH-11406017 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals diagnosed with AD or ADRD who rely on ongoing prescribed medications and have caregiver support or involvement.
✕Less likely to help
Patients without a caregiving support network or those not on multiple daily medications may see limited benefit.
What this research studies
This project aims to bring a pharmacy-integrated, AI-driven HomeCare System to people living with Alzheimer’s disease or related dementias. The system uses habit-forming techniques and AI-enabled adherence tracking to improve how medications are taken and shared with pharmacists. It builds on prior NIH work to create a seamless connection between home care, pharmacies, and clinical outcomes. The effort focuses on reducing unnecessary hospitalizations, delaying institutional care, and lowering caregiver burden.
Why it matters
Potential benefit: If successful, it could improve daily medication adherence, reduce hospitalizations, and support families caring for someone with AD/ADRD.
How similar studies have gone: Previous NIH-funded work suggests AI-driven adherence tools can improve medication accountability and outcomes, but this specific HomeCare System will demonstrate real-world applicability in AD/ADRD care.
Where this research is happening
-
Hido Technologies, INC.
El Dorado Hills, United States Active
Researchers
- Principal investigator: Gellman, Charles — Hido Technologies, INC.
- Study coordinator: Gellman, Charles
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.